Company Analysis

Evotec SE (EVO)

Nasdaq: EVO · Pharmaceutical Preparations · Hamburg, DE · filing with the SEC since 2007
Grade5.1
◀ Past 6.5● Present 5.6▶ Future 3.0
1 est.

The company now

Evotec SE is classed by the SEC under Pharmaceutical Preparations (industry code 2834), based in Hamburg, DE. In its latest annual figures on file, for the fiscal year ended 2024-12-31, it reported revenue of EUR 797 million and a loss of EUR 196 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.

SI Assistanton EVO · research, not advice